Sandy Chin is a woman who knows the meaning of the word mentor. She has become one of the premier women in the stock portfolio industry. She was a political science major in her college years and almost went to law school. When she saw an opportunity to work at Donaldson, Lufkin, and Jenrette she took advantage of it. Over the years she has been mentored by a man named Bill Leach and she has never looked back. She is now making her own mark to the selling and buying of consumer staple stocks. Things have come full circle for Sandy Chin.
Sandy Chin talked with interview.net about her career and what it meant to be mentored by Bill Leach. She says he was a great teacher and could give her the inside track on what it means to buy and sell stocks for a living. She says that she was only one of two associates that he has hired over twenty years. She said that she learned by being able to attend meetings and tag along with him. She says that he is one of the top men in the business. She was able to discern what body language to use during conferences and how to value stocks in the short and long-term.
Sandy Chin says that she learned valuable lessons from Bill Leach over the years. One of the most important things she learned was to not pass up a chance to have a meeting with a new small company. New companies can provide stock sellers and buyers with new insights into the industry. Another important lesson she learned was to ask lots of questions during meetings or phone calls with other analysts. By doing this, one can develop friendships with other analysts in the business and the answers analysts give can give insight into future movements of certain stocks or the market altogether. One final thing she learned was to invest her own money. When she did this it gave her keen insight into how the stocks fluctuate and she can give personal experience to other investors in the field.
Sandy Chin would not be where she is today without the help of those around her and her mentor Bill Leach. Taking the time to learn is just as important as taking the time to mentor future analysts. This is how Sandy Chin got to the top.
There are all kinds of health-related problems out there that are affecting people in negative ways. Luckily, men like Marc Beer are dedicated to finding new ways to combat these illnesses and he is currently doing so with his latest company, Renovia. Renovia is a new startup by Marc, but they have already received quite a large amount of funding and traction throughout their region. More than 40 million dollars was raised during Marc’s Series B funding round. Renovia is currently focused on a particular disease, one which is primarily related to women known as pelvic floor disorder. Women of nearly all ages can get this disease which is majorly difficult to live with on a daily basis, especially in more severe cases.
Marc Beer has spent most of his career working at different pharmaceutical companies, specializing both in research as well as the development of products. With more than 20 years of experience behind him in the industry today, Marc is well prepared for his journey with Renovia Inc and he has been incredibly successful thus far. As the Chief Executive Officer and chairman for Renovia, it has become his primary focus in life and his career ever since 2016 when he started up the company.
Marc’s academic career consists of a bachelors degree from Miami University, which was more than sufficient to get him started in business for himself. Since finishing his education, Marc Beer has become experienced in many different areas, including sales, marketing, pharmaceuticals, and more, which contribute to his success as a businessman today. In the past, he has served as Viacell’s CEO and director for Abbot Labs. The experience he gained working for these companies has given him the leadership skills he needed to successful managed Renovia as a healthcare company.
Renovia has two co-founders as well that helped Marc launch the company, though Marc is responsible for backing the initial funds to start off the company. So far, their efforts have been successful in developing Leva, their first drug to treat pelvic floor disorder. In less than two years, Renovia has created a seemingly effective treatment that has already been approved by the FDA. With more funding, Renovia could improve the technology behind Leva and make it more portable for women so that distribution can be greater and easier on an international scale. Learn more: https://www.linkedin.com/in/marcbeer